Rei Suzuki
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment 12
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 16
-
- Gastric Cancer Management and Outcomes 16
- Metastasis and carcinoma case studies 12
-
- Pancreatitis Pathology and Treatment 11
- Gastrointestinal disorders and treatments 7
-
- Neuroendocrine Tumor Research Advances 6
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Co-authors
- Manoop S. BhutaniAtsushi IrisawaHiromasa OhiraSrinadh AnnangiSushovan GuhaTakuto HikichiKatsutoshi ObaraNirav Thosani
- Journals
- SHILAP Revista de lepidopterología (2 papers)International Journal of Pharmaceutics (1 paper)eLife (1 paper)
- Partner nations
- JapanUnited StatesRomania
In The Last Decade
Rei Suzuki
52 papers receiving 486 citations
Peers
Comparison fields: 5 of 65
- Gastroenterology 61
- Oncology 267
- Pulmonary and Respiratory Medicine 205
- Surgery 272
- Epidemiology 109
Countries citing papers authored by Rei Suzuki
This map shows the geographic impact of Rei Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rei Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rei Suzuki more than expected).
Fields of papers citing papers by Rei Suzuki
This network shows the impact of papers produced by Rei Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rei Suzuki. The network helps show where Rei Suzuki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rei Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2021 | 8 | |
| 3 | 2021 | 6 | |
| 4 | 2020 | 5 | |
| 5 | 2016 | 3 | |
| 6 | 2016 | 3 | |
| 7 | 2016 | 32 | |
| 8 | 2015 | 9 | |
| 9 | 2015 | 4 | |
| 10 | 2014 | 36 | |
| 11 | 2014 | 7 | |
| 12 | 2013 | 4 | |
| 13 | 2012 | 1 | |
| 14 | 2011 | 3 | |
| 15 | 2011 | 1 | |
| 16 | 2011 | 2 | |
| 17 | 2010 | 12 | |
| 18 | 2010 | 28 | |
| 19 | 2009 | 10 | |
| 20 | 2009 | 8 |
About Rei Suzuki
Rei Suzuki is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Surgery, having authored 55 papers that have together received 498 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (16 papers), Gastric Cancer Management and Outcomes (16 papers), Gastrointestinal Tumor Research and Treatment (12 papers), Metastasis and carcinoma case studies (12 papers), Pancreatitis Pathology and Treatment (11 papers), Gastrointestinal disorders and treatments (7 papers), Neuroendocrine Tumor Research Advances (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Gastroenterology (61 citations), Oncology (267 citations) and Pulmonary and Respiratory Medicine (205 citations). Rei Suzuki has collaborated with scholars based in Japan, United States and Romania. Frequent co-authors include Manoop S. Bhutani, Atsushi Irisawa, Hiromasa Ohira, Srinadh Annangi, Sushovan Guha, Takuto Hikichi, Katsutoshi Obara, Nirav Thosani, Tadayuki Takagi and Jun Nakamura. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and eLife.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.